|
US4057685A
(en)
|
1972-02-02 |
1977-11-08 |
Abbott Laboratories |
Chemically modified endotoxin immunizing agent
|
|
US4315919A
(en)
*
|
1980-10-06 |
1982-02-16 |
Edward Shanbrom |
Depyrogenation process
|
|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
|
SE8205892D0
(sv)
|
1982-10-18 |
1982-10-18 |
Bror Morein |
Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
|
|
US4459286A
(en)
|
1983-01-31 |
1984-07-10 |
Merck & Co., Inc. |
Coupled H. influenzae type B vaccine
|
|
US4663160A
(en)
|
1983-03-14 |
1987-05-05 |
Miles Laboratories, Inc. |
Vaccines for gram-negative bacteria
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4761283A
(en)
|
1983-07-05 |
1988-08-02 |
The University Of Rochester |
Immunogenic conjugates
|
|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
|
US6090406A
(en)
|
1984-04-12 |
2000-07-18 |
The Liposome Company, Inc. |
Potentiation of immune responses with liposomal adjuvants
|
|
US5916588A
(en)
|
1984-04-12 |
1999-06-29 |
The Liposome Company, Inc. |
Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
|
|
US4882317A
(en)
|
1984-05-10 |
1989-11-21 |
Merck & Co., Inc. |
Covalently-modified bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers and methods of preparing such polysaccharides and conjugataes and of confirming covalency
|
|
US4695624A
(en)
|
1984-05-10 |
1987-09-22 |
Merck & Co., Inc. |
Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency
|
|
US4808700A
(en)
|
1984-07-09 |
1989-02-28 |
Praxis Biologics, Inc. |
Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
|
|
IT1187753B
(it)
|
1985-07-05 |
1987-12-23 |
Sclavo Spa |
Coniugati glicoproteici ad attivita' immunogenica trivalente
|
|
US4777127A
(en)
|
1985-09-30 |
1988-10-11 |
Labsystems Oy |
Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
|
|
US4680338A
(en)
|
1985-10-17 |
1987-07-14 |
Immunomedics, Inc. |
Bifunctional linker
|
|
US5011828A
(en)
|
1985-11-15 |
1991-04-30 |
Michael Goodman |
Immunostimulating guanine derivatives, compositions and methods
|
|
GB8702816D0
(en)
|
1987-02-07 |
1987-03-11 |
Al Sumidaie A M K |
Obtaining retrovirus-containing fraction
|
|
US5219740A
(en)
|
1987-02-13 |
1993-06-15 |
Fred Hutchinson Cancer Research Center |
Retroviral gene transfer into diploid fibroblasts for gene therapy
|
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
|
US5206152A
(en)
|
1988-04-08 |
1993-04-27 |
Arch Development Corporation |
Cloning and expression of early growth regulatory protein genes
|
|
US5422120A
(en)
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
|
AP129A
(en)
|
1988-06-03 |
1991-04-17 |
Smithkline Biologicals S A |
Expression of retrovirus gag protein eukaryotic cells
|
|
NL8802046A
(nl)
|
1988-08-18 |
1990-03-16 |
Gen Electric |
Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
|
|
AU627226B2
(en)
|
1988-08-25 |
1992-08-20 |
Liposome Company, Inc., The |
Influenza vaccine and novel adjuvants
|
|
DE3841091A1
(de)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
|
|
US5238944A
(en)
|
1988-12-15 |
1993-08-24 |
Riker Laboratories, Inc. |
Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
|
|
JP3237842B2
(ja)
|
1988-12-16 |
2001-12-10 |
オランダ国 |
ニューモリシンミュータント及びそれから製造されたニューモコッカルワクチン
|
|
US6716432B1
(en)
|
1988-12-16 |
2004-04-06 |
James Cleland Paton |
Pneumolysin mutants and pneumococcal vaccines made therefrom
|
|
CA2006700A1
(en)
|
1989-01-17 |
1990-07-17 |
Antonello Pessi |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
EP0832980B1
(en)
|
1989-01-23 |
2002-06-19 |
Chiron Corporation |
Recombinant therapies for infection and hyperproliferative disorders
|
|
DK0737750T3
(da)
|
1989-03-21 |
2003-09-01 |
Vical Inc |
Ekspression af exogene polynucleotidsekvenser i vertebrater
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US4929624A
(en)
|
1989-03-23 |
1990-05-29 |
Minnesota Mining And Manufacturing Company |
Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
|
|
WO1990014837A1
(en)
|
1989-05-25 |
1990-12-13 |
Chiron Corporation |
Adjuvant formulation comprising a submicron oil droplet emulsion
|
|
AU651949B2
(en)
|
1989-07-14 |
1994-08-11 |
American Cyanamid Company |
Cytokine and hormone carriers for conjugate vaccines
|
|
EP1001032A3
(en)
|
1989-08-18 |
2005-02-23 |
Chiron Corporation |
Recombinant retroviruses delivering vector constructs to target cells
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US4988815A
(en)
|
1989-10-26 |
1991-01-29 |
Riker Laboratories, Inc. |
3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
|
|
IT1237764B
(it)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
|
|
ZA911974B
(en)
|
1990-03-21 |
1994-08-22 |
Res Dev Foundation |
Heterovesicular liposomes
|
|
US5658731A
(en)
|
1990-04-09 |
1997-08-19 |
Europaisches Laboratorium Fur Molekularbiologie |
2'-O-alkylnucleotides as well as polymers which contain such nucleotides
|
|
SE466259B
(sv)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
|
|
US5149655A
(en)
|
1990-06-21 |
1992-09-22 |
Agracetus, Inc. |
Apparatus for genetic transformation
|
|
GB2276169A
(en)
|
1990-07-05 |
1994-09-21 |
Celltech Ltd |
Antibodies specific for carcinoembryonic antigen
|
|
ATE128628T1
(de)
|
1990-08-13 |
1995-10-15 |
American Cyanamid Co |
Faser-hemagglutinin von bordetella pertussis als träger für konjugierten impfstoff.
|
|
ATE190354T1
(de)
|
1990-12-20 |
2000-03-15 |
Arch Dev Corp The University O |
Kontrolle der genexpression durch ionisierende strahlung
|
|
US5389640A
(en)
|
1991-03-01 |
1995-02-14 |
Minnesota Mining And Manufacturing Company |
1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
DE69229114T2
(de)
|
1991-03-01 |
1999-11-04 |
Minnesota Mining And Mfg. Co., Saint Paul |
1,2-substituierte 1h-imidazo[4,5-c]chinolin-4-amine
|
|
ATE237694T1
(de)
|
1991-08-20 |
2003-05-15 |
Us Gov Health & Human Serv |
Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
|
|
US5936076A
(en)
|
1991-08-29 |
1999-08-10 |
Kirin Beer Kabushiki Kaisha |
αgalactosylceramide derivatives
|
|
US5268376A
(en)
|
1991-09-04 |
1993-12-07 |
Minnesota Mining And Manufacturing Company |
1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
|
|
US5266575A
(en)
|
1991-11-06 |
1993-11-30 |
Minnesota Mining And Manufacturing Company |
2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
|
|
WO1993010218A1
(en)
|
1991-11-14 |
1993-05-27 |
The United States Government As Represented By The Secretary Of The Department Of Health And Human Services |
Vectors including foreign genes and negative selective markers
|
|
GB9125623D0
(en)
|
1991-12-02 |
1992-01-29 |
Dynal As |
Cell modification
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
FR2688514A1
(fr)
|
1992-03-16 |
1993-09-17 |
Centre Nat Rech Scient |
Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
|
|
IL105325A
(en)
|
1992-04-16 |
1996-11-14 |
Minnesota Mining & Mfg |
Immunogen/vaccine adjuvant composition
|
|
EP0650370A4
(en)
|
1992-06-08 |
1995-11-22 |
Univ California |
METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
|
|
EP0644946A4
(en)
|
1992-06-10 |
1997-03-12 |
Us Health |
VECTOR PARTICLES RESISTANT TO INACTIVATION BY HUMAN SERUM.
|
|
DE69313134T2
(de)
|
1992-06-25 |
1998-02-26 |
Smithkline Beecham Biolog |
Adjuvantien enthaltende impfstoffzusammensetzung
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
GB2269175A
(en)
|
1992-07-31 |
1994-02-02 |
Imperial College |
Retroviral vectors
|
|
EP0673431A1
(en)
|
1992-12-03 |
1995-09-27 |
Genzyme Corporation |
Gene therapy for cystic fibrosis
|
|
US5395937A
(en)
|
1993-01-29 |
1995-03-07 |
Minnesota Mining And Manufacturing Company |
Process for preparing quinoline amines
|
|
KR100310510B1
(ko)
|
1993-03-23 |
2002-07-04 |
장 스테판느 |
3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물
|
|
AU6818094A
(en)
|
1993-04-22 |
1994-11-08 |
Depotech Corporation |
Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
|
|
EP0705344B8
(en)
|
1993-06-24 |
2006-05-10 |
Advec Inc. |
Adenovirus vectors for gene therapy
|
|
US5352784A
(en)
|
1993-07-15 |
1994-10-04 |
Minnesota Mining And Manufacturing Company |
Fused cycloalkylimidazopyridines
|
|
DK0708772T3
(da)
|
1993-07-15 |
2000-09-18 |
Minnesota Mining & Mfg |
Imidazo[4,5,-c]pyridin-4-aminer
|
|
WO1995007994A2
(en)
|
1993-09-15 |
1995-03-23 |
Viagene, Inc. |
Recombinant alphavirus vectors
|
|
US6015686A
(en)
|
1993-09-15 |
2000-01-18 |
Chiron Viagene, Inc. |
Eukaryotic layered vector initiation systems
|
|
DE69435223D1
(de)
|
1993-10-25 |
2009-09-03 |
Canji Inc |
Rekombinanter Adenoviren-Vektor und Verfahren zur Verwendung
|
|
WO1995011700A1
(en)
|
1993-10-29 |
1995-05-04 |
Pharmos Corp. |
Submicron emulsions as vaccine adjuvants
|
|
HUT75162A
(en)
|
1993-11-16 |
1997-04-28 |
Depotech Corp |
Vesicles with controlled release of actives
|
|
GB9326174D0
(en)
|
1993-12-22 |
1994-02-23 |
Biocine Sclavo |
Mucosal adjuvant
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
DE69535669T2
(de)
|
1994-05-09 |
2008-12-04 |
Oxford Biomedica (Uk) Ltd. |
Retrovirale vektoren mit verminderter rekombinationsrate
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
|
WO1996017072A2
(en)
|
1994-11-30 |
1996-06-06 |
Chiron Viagene, Inc. |
Recombinant alphavirus vectors
|
|
US5482936A
(en)
|
1995-01-12 |
1996-01-09 |
Minnesota Mining And Manufacturing Company |
Imidazo[4,5-C]quinoline amines
|
|
UA56132C2
(uk)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
US5707829A
(en)
|
1995-08-11 |
1998-01-13 |
Genetics Institute, Inc. |
DNA sequences and secreted proteins encoded thereby
|
|
US20020028215A1
(en)
*
|
1999-08-09 |
2002-03-07 |
Jagath L. Kadurugamuwa |
Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
|
|
DE69739286D1
(de)
|
1996-05-06 |
2009-04-16 |
Oxford Biomedica Ltd |
Rekombinationsunfähige retrovirale vektoren
|
|
ATE348887T1
(de)
|
1996-10-31 |
2007-01-15 |
Human Genome Sciences Inc |
Streptococcus pneumoniae antigene und impfstoffe
|
|
AU753688B2
(en)
|
1997-03-10 |
2002-10-24 |
Ottawa Civic Loeb Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US6818222B1
(en)
|
1997-03-21 |
2004-11-16 |
Chiron Corporation |
Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants
|
|
US6080725A
(en)
|
1997-05-20 |
2000-06-27 |
Galenica Pharmaceuticals, Inc. |
Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
AU740956B2
(en)
|
1997-07-21 |
2001-11-15 |
Baxter Healthcare Sa |
Modified immunogenic pneumolysin compositions as vaccines
|
|
EP1279401B1
(en)
|
1997-09-05 |
2008-01-09 |
GlaxoSmithKline Biologicals S.A. |
Oil in water emulsions containing saponins
|
|
GB9725084D0
(en)
|
1997-11-28 |
1998-01-28 |
Medeva Europ Ltd |
Vaccine compositions
|
|
CN1200730C
(zh)
|
1998-02-12 |
2005-05-11 |
惠氏控股有限公司 |
用白细胞介素－12配制的肺炎球菌和脑膜炎球菌疫苗
|
|
US7018637B2
(en)
|
1998-02-23 |
2006-03-28 |
Aventis Pasteur, Inc |
Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines
|
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
|
BR9909915A
(pt)
|
1998-04-09 |
2000-12-26 |
Smithkline Beecham Biolog |
Composições adjuvantes
|
|
WO1999053940A1
(en)
|
1998-04-23 |
1999-10-28 |
Uab Research Foundation |
PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR
|
|
CA2330610A1
(en)
|
1998-05-07 |
1999-11-11 |
Corixa Corporation |
Adjuvant composition and methods for its use
|
|
US6562798B1
(en)
|
1998-06-05 |
2003-05-13 |
Dynavax Technologies Corp. |
Immunostimulatory oligonucleotides with modified bases and methods of use thereof
|
|
WO2000006737A2
(en)
|
1998-07-27 |
2000-02-10 |
Microbial Technics Limited |
Streptococcus pneumoniae proteins and nucleic acid molecules
|
|
EP1144640A3
(en)
|
1998-07-27 |
2001-11-28 |
Microbial Technics Limited |
Nucleic acids and proteins from streptococcus pneumoniae
|
|
US20030134407A1
(en)
*
|
1998-07-27 |
2003-07-17 |
Le Page Richard William Falla |
Nucleic acids and proteins from Streptococcus pneumoniae
|
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
|
CN1263510C
(zh)
|
1998-08-19 |
2006-07-12 |
巴克斯特健康护理股份有限公司 |
多糖－蛋白质缀合物或寡糖－蛋白质缀合物、其制备方法及其应用
|
|
ES2284287T3
(es)
|
1998-10-16 |
2007-11-01 |
Glaxosmithkline Biologicals S.A. |
Sistemas adyuvantes y vacunas.
|
|
WO2000033882A1
(en)
|
1998-12-04 |
2000-06-15 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
A vi-repa conjugate vaccine for immunization against salmonella typhi
|
|
CA2355364C
(en)
|
1998-12-21 |
2014-03-18 |
Medimmune, Inc. |
Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
|
|
US20030130212A1
(en)
|
1999-01-14 |
2003-07-10 |
Rossignol Daniel P. |
Administration of an anti-endotoxin drug by intravenous infusion
|
|
US6551600B2
(en)
|
1999-02-01 |
2003-04-22 |
Eisai Co., Ltd. |
Immunological adjuvant compounds compositions and methods of use thereof
|
|
US6355271B1
(en)
|
1999-02-03 |
2002-03-12 |
Biosante Pharmaceuticals, Inc. |
Therapeutic calcium phosphate particles and methods of manufacture and use
|
|
CA2366152A1
(en)
|
1999-03-19 |
2000-09-28 |
Smithkline Beecham Biologicals S.A. |
Streptococcus pneumoniae vaccine
|
|
CN1198932C
(zh)
|
1999-03-26 |
2005-04-27 |
科特克斯(Om)有限公司 |
肺炎链球菌抗原
|
|
WO2000061761A2
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
AU777856B2
(en)
|
1999-06-10 |
2004-11-04 |
Human Genome Sciences, Inc. |
Streptococcus pneumoniae proteins and vaccines
|
|
EP1075841A1
(en)
|
1999-08-13 |
2001-02-14 |
Erasmus Universiteit Rotterdam |
Pneumococcal vaccines
|
|
IL148671A0
(en)
|
1999-09-24 |
2002-09-12 |
Smithkline Beecham Biolog |
Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
|
|
HK1049106A1
(zh)
|
1999-09-24 |
2003-05-02 |
Smithkline Beecham Biologicals S.A. |
聚氧化乙烯山梨糖酯和octooxynol的聯用做為佐劑和其在疫苗中的用途
|
|
WO2001022972A2
(en)
|
1999-09-25 |
2001-04-05 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acids
|
|
US20010044416A1
(en)
|
2000-01-20 |
2001-11-22 |
Mccluskie Michael J. |
Immunostimulatory nucleic acids for inducing a Th2 immune response
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
CA2407455A1
(en)
|
2000-04-27 |
2001-11-01 |
Medimmune, Inc. |
Immunogenic pneumococcal protein and vaccine compositions thereof
|
|
US20040091495A1
(en)
|
2000-07-20 |
2004-05-13 |
Lars Bjorck |
Protein
|
|
JP4341949B2
(ja)
|
2000-09-01 |
2009-10-14 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
アザ複素環式誘導体およびその治療的使用
|
|
BRPI0113757B8
(pt)
|
2000-09-11 |
2017-11-07 |
Chiron Corp |
derivados de quinolinona como inibidores de tirosina quinase
|
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
|
EP2292632A3
(en)
|
2000-09-26 |
2012-07-25 |
Idera Pharmaceuticals, Inc. |
Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
|
|
CA2426738A1
(en)
|
2000-10-26 |
2002-05-02 |
David William Holden |
Streptococcal genes
|
|
US6664260B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Heterocyclic ether substituted imidazoquinolines
|
|
US6677347B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
|
US6660747B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
|
US6664264B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
|
US6667312B2
(en)
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
|
US6664265B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
|
US6677348B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Aryl ether substituted imidazoquinolines
|
|
US6660735B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Urea substituted imidazoquinoline ethers
|
|
UA74852C2
(en)
|
2000-12-08 |
2006-02-15 |
3M Innovative Properties Co |
Urea-substituted imidazoquinoline ethers
|
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
|
GB0108079D0
(en)
|
2001-03-30 |
2001-05-23 |
Microbial Technics Ltd |
Protein
|
|
AU2002309706A1
(en)
|
2001-05-11 |
2002-11-25 |
Aventis Pasteur, Inc. |
Novel meningitis conjugate vaccine
|
|
EP1450856B1
(en)
|
2001-09-14 |
2009-11-11 |
Cytos Biotechnology AG |
Packaging of immunostimulatory cpg into virus-like particles: method of preparation and use
|
|
EP1425040A2
(en)
|
2001-09-14 |
2004-06-09 |
Cytos Biotechnology AG |
In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
|
|
WO2003035836A2
(en)
|
2001-10-24 |
2003-05-01 |
Hybridon Inc. |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
|
|
WO2003045968A1
(en)
|
2001-11-27 |
2003-06-05 |
Anadys Pharmaceuticals, Inc. |
3-β-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
|
|
US7321033B2
(en)
|
2001-11-27 |
2008-01-22 |
Anadys Pharmaceuticals, Inc. |
3-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereof
|
|
US6677349B1
(en)
|
2001-12-21 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
|
MXPA04009541A
(es)
|
2002-03-29 |
2005-01-25 |
Chiron Corp |
Benzazoles sustituidos y uso de los mismos como inhibidores de cinasa raf.
|
|
EP2275127B1
(en)
|
2002-04-02 |
2012-09-19 |
Ben Gurion University Of The Negev Research And Development Authority |
Protein-based streptococcus pneumoniae vaccines
|
|
WO2003101949A2
(en)
|
2002-05-29 |
2003-12-11 |
3M Innovative Properties Company |
Process for imidazo[4,5-c]pyridin-4-amines
|
|
RU2004135541A
(ru)
|
2002-06-11 |
2005-10-10 |
ГлаксоСмитКлайн Байолоджикалз с.а. (BE) |
Иммуногенные композиции
|
|
WO2003105769A2
(en)
|
2002-06-13 |
2003-12-24 |
New York University |
Synthetic c-glycolipid and its use for treating cancer infectious diseases and autoimmune diseases
|
|
CA2496246A1
(en)
|
2002-08-23 |
2004-03-04 |
Chiron Corporation |
Pyrrole based inhibitors of glycogen synthase kinase 3
|
|
AU2003268353A1
(en)
*
|
2002-08-30 |
2004-03-19 |
Tufts University |
Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
|
|
CN100443116C
(zh)
|
2002-11-07 |
2008-12-17 |
新纳几美国公司 |
治疗或预防肺炎球菌感染的组合物及其用途
|
|
CA2511646A1
(en)
|
2002-12-27 |
2004-07-22 |
Chiron Corporation |
Thiosemicarbazones as anti-virals and immunopotentiators
|
|
WO2004064759A2
(en)
|
2003-01-21 |
2004-08-05 |
Chiron Corporation |
Use of tryptanthrin compounds for immune potentiation
|
|
GB0301554D0
(en)
|
2003-01-23 |
2003-02-26 |
Molecularnature Ltd |
Immunostimulatory compositions
|
|
WO2004087153A2
(en)
|
2003-03-28 |
2004-10-14 |
Chiron Corporation |
Use of organic compounds for immunopotentiation
|
|
US7635487B2
(en)
*
|
2003-04-15 |
2009-12-22 |
Intercell Ag |
S. pneumoniae antigens
|
|
RU2236257C1
(ru)
|
2003-09-15 |
2004-09-20 |
Косяков Константин Сергеевич |
Синтетический иммуноген для терапии и профилактики злоупотреблений наркотическими и психоактивными веществами
|
|
US7771726B2
(en)
|
2003-10-08 |
2010-08-10 |
New York University |
Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases
|
|
JP4646806B2
(ja)
|
2003-12-31 |
2011-03-09 |
スンギュンカン ユニバーシティ |
組み換え肺炎球菌ＣｌｐＰ蛋白質を含むワクチン
|
|
CA2560969A1
(en)
|
2004-03-31 |
2005-11-03 |
New York University |
Novel synthetic c-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases
|
|
KR20110132416A
(ko)
|
2004-04-05 |
2011-12-07 |
화이자 프로덕츠 인코포레이티드 |
미세유체화된 수중유 유화액 및 백신 조성물
|
|
GB0410220D0
(en)
|
2004-05-07 |
2004-06-09 |
Kirkham Lea Ann |
Mutant pneumolysin proteins
|
|
CA2597489A1
(en)
*
|
2005-02-11 |
2006-08-17 |
Ace Biosciences A/S |
Surface-located streptococcus pneumoniae polypeptides
|
|
US7955605B2
(en)
|
2005-04-08 |
2011-06-07 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US20060228369A1
(en)
|
2005-04-11 |
2006-10-12 |
Program For Appropriate Technology In Health |
Stabilization and preservation of temperature-sensitive vaccines
|
|
US7691368B2
(en)
|
2005-04-15 |
2010-04-06 |
Merial Limited |
Vaccine formulations
|
|
KR20080027777A
(ko)
*
|
2005-06-01 |
2008-03-28 |
배리에이션 바이오테크놀로지스 아이엔씨. |
펩티드기초 인플루엔자 백신 제제
|
|
HUE045482T2
(hu)
|
2005-06-27 |
2019-12-30 |
Glaxosmithkline Biologicals Sa |
Immunogén készítmény
|
|
US8703095B2
(en)
|
2005-07-07 |
2014-04-22 |
Sanofi Pasteur S.A. |
Immuno-adjuvant emulsion
|
|
JP5792920B2
(ja)
|
2005-12-22 |
2015-10-14 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
ワクチン
|
|
FR2896162B1
(fr)
|
2006-01-13 |
2008-02-15 |
Sanofi Pasteur Sa |
Emulsion huile dans eau thermoreversible
|
|
WO2007116322A2
(en)
|
2006-02-17 |
2007-10-18 |
Novartis Ag |
Purification of bacterial antigens
|
|
NZ572054A
(en)
*
|
2006-03-22 |
2011-12-22 |
Novartis Ag |
Regimens for immunisation with meningococcal conjugates
|
|
CA2664619C
(en)
|
2006-10-12 |
2012-12-11 |
Glaxosmithkline Biologicals S.A. |
Immunogenic compositions comprising an oil-in-water emulsion adjuvant containing a reduced amount of squalene, tocol and an emulsifying agent
|
|
EP1923069A1
(en)
|
2006-11-20 |
2008-05-21 |
Intercell AG |
Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto
|
|
RU2636350C2
(ru)
*
|
2011-11-07 |
2017-11-22 |
Новартис Аг |
МОЛЕКУЛА, СОДЕРЖАЩАЯ SPR0096 и SPR2021
|